← TrialMatch
HomeTrials

Diagnostic Value of Deep Learning-Based Rapid MRI in Preoperative Evaluation of Acute Chol

This is a single-center, prospective observational study at Peking Union Medical College Hospital. The main goal is to evaluate the image quality and clinical value of a new fast abdominopelvic MRI sequence that uses deep learning-based reconstruction. The study will include adult patients (18 years or older) who need

Condition(s)Acute Cholecystitis
StatusRecruiting
Study typeObservational
SummaryThis is a single-center, prospective observational study at Peking Union Medical College Hospital. The main goal is to evaluate the image quality and clinical value of a new fast abdominopelvic MRI sequence that uses deep learning-based reconstruction. The study will include adult patients (18 years or older) who need an MRI scan of the abdomen or pelvis as part of their routine care. These patients will receive both the standard MRI sequence and the new fast sequence, with the goal of comparing the two. The fast sequence is designed to be shorter (5-8 minutes) while maintaining or improving image quality, which can help reduce patient discomfort and motion-related artifacts. Radiologists will assess the quality of the images from both sequences. The study will also look at how well the fa
Who can participateInclusion Criteria: * Age ≥ 18 years * Clinical indication for abdominopelvic MRI examination * Able to understand and sign the informed consent form * Able to lie supine and cooperate with breath-holding/respiratory commands during MRI Exclusion Criteria: * Presence of absolute contraindications to MRI (e.g., pacemaker, ferromagnetic foreign body, severe claustrophobia) * Inability to complete the MRI scan due to severe pain, instability, or altered mental status * Pregnant or breastfeeding women (unless explicitly approved by protocol) * Previous abdominal/pelvic surgery with contraindications to MRI sequences
Ages18 Years
SexAll
Lead sponsorPeking Union Medical College Hospital
LocationsBeijing, Beijing Municipality, China
Start date2024-06-01
NCT IDNCT07551375
Official listinghttps://clinicaltrials.gov/study/NCT07551375

🔍 Search all trials →